These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7591736)

  • 21. Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.
    Cole JC; Lin P; Rupnow MF
    Qual Life Res; 2007 Sep; 16(7):1231-7. PubMed ID: 17468941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumatriptan-nonresponders: a survey in 366 migraine patients.
    Visser WH; de Vriend RH; Jaspers NH; Ferrari MD
    Headache; 1996 Sep; 36(8):471-5. PubMed ID: 8824001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of sumamigren at early and late stages of migraine attack].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):29-33. PubMed ID: 18379469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
    Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
    Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumatriptan use in a large group-model health maintenance organization.
    Greiner DL; Addy SN
    Am J Health Syst Pharm; 1996 Mar; 53(6):633-8. PubMed ID: 8800968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
    Cady RK; Gutterman D; Saiers JA; Beach ME
    Cephalalgia; 1997 Aug; 17(5):588-90. PubMed ID: 9251874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of acute attack of migraine with sumatriptan].
    González-Espinosa LE; Gómez-Viera N; Olivera-Leal I; Reyes-Lorente R
    Rev Neurol; 1997 Nov; 25(147):1672-5. PubMed ID: 9484515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
    Lampl C; Voelker M; Diener HC
    J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sumatriptan use in patients with migraine.
    Canario JR; Shenenberger DW
    Mayo Clin Proc; 2002 Feb; 77(2):201. PubMed ID: 11838657
    [No Abstract]   [Full Text] [Related]  

  • 34. A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.
    Dahlöf C; Bouchard J; Cortelli P; Heywood J; Jansen JP; Pham S; Hirsch J; Adams J; Miller DW
    Pharmacoeconomics; 1997; 11 Suppl 1():24-34. PubMed ID: 10168040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 27-year-old woman with migraine headaches.
    Welch KM
    JAMA; 1997 Jul 23-30; 278(4):322-8. PubMed ID: 9228439
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
    Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
    Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 27-year-old woman with migraine headaches, 1 year later.
    Daley J; Delbanco TL; Hartman EE
    JAMA; 1998 Mar; 279(12):954. PubMed ID: 9544771
    [No Abstract]   [Full Text] [Related]  

  • 38. Sumatriptan prophylaxis for postelectroconvulsive therapy headaches.
    DeBattista C; Mueller K
    Headache; 1995 Sep; 35(8):502-3. PubMed ID: 7591748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
    Visser WH; Terwindt GM; Reines SA; Jiang K; Lines CR; Ferrari MD
    Arch Neurol; 1996 Nov; 53(11):1132-7. PubMed ID: 8912486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.